Babesia duncani as a Model Organism to Study the Development, Virulence, and Drug Susceptibility of Intraerythrocytic Parasites In Vitro and In Vivo . (4th May 2022)
- Record Type:
- Journal Article
- Title:
- Babesia duncani as a Model Organism to Study the Development, Virulence, and Drug Susceptibility of Intraerythrocytic Parasites In Vitro and In Vivo . (4th May 2022)
- Main Title:
- Babesia duncani as a Model Organism to Study the Development, Virulence, and Drug Susceptibility of Intraerythrocytic Parasites In Vitro and In Vivo
- Authors:
- Pal, Anasuya C
Renard, Isaline
Singh, Pallavi
Vydyam, Pratap
Chiu, Joy E
Pou, Sovitj
Winter, Rolf W
Dodean, Rozalia
Frueh, Lisa
Nilsen, Aaron C
Riscoe, Michael K
Doggett, J Stone
Ben Mamoun, Choukri - Abstract:
- Abstract: Human babesiosis is a malaria-like illness caused by tick-borne intraerythrocytic Babesia parasites of the Apicomplexa phylum. Whereas several species of Babesia can cause severe disease in humans, the ability to propagate Babesia duncani both in vitro in human erythrocytes and in mice makes it a unique pathogen to study Babesia biology and pathogenesis. Here we report an optimized B. duncani in culture–in mouse (ICIM) model that combines continuous in vitro culture of the parasite with a precise model of lethal infection in mice. We demonstrate that B. duncani –infected erythrocytes as well as free merozoites can cause lethal infection in C3H/HeJ mice. Highly reproducible parasitemia and survival outcomes could be established using specific parasite loads in different mouse genetic backgrounds. Using the ICIM model, we discovered 2 new endochin-like quinolone prodrugs (ELQ-331 and ELQ-468) that alone or in combination with atovaquone are highly efficacious against B. duncani and Babesia microti . Abstract : We describe an optimized Babesia duncani in culture–in mouse model that combines continuous parasite replication in human erythrocytes and lethal infection in mice. Study findings support the use of this model to study Babesia virulence and develop new therapies for human babesiosis.
- Is Part Of:
- Journal of infectious diseases. Volume 226:Number 7(2022)
- Journal:
- Journal of infectious diseases
- Issue:
- Volume 226:Number 7(2022)
- Issue Display:
- Volume 226, Issue 7 (2022)
- Year:
- 2022
- Volume:
- 226
- Issue:
- 7
- Issue Sort Value:
- 2022-0226-0007-0000
- Page Start:
- 1267
- Page End:
- 1275
- Publication Date:
- 2022-05-04
- Subjects:
- babesiosis -- Babesia duncani -- erythrocytes -- Apicomplexa -- parasite
Communicable diseases -- Periodicals
Diseases -- Causes and theories of causation -- Periodicals
Medicine -- Periodicals
Communicable Diseases -- Periodicals
Electronic journals
616.9 - Journal URLs:
- http://jid.oxfordjournals.org/content/by/year ↗
http://www.journals.uchicago.edu/JID/journal/ ↗
http://www.jstor.org/journals/00221899.html ↗
http://ukcatalogue.oup.com/ ↗ - DOI:
- 10.1093/infdis/jiac181 ↗
- Languages:
- English
- ISSNs:
- 0022-1899
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5006.700000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23976.xml